Sha Mi

This inventor holds 34 USPTO granted patents and 29 published patent applications, plus 9 CIPO patents and 18 EPO patents, primarily in Demyelinating Disorders. Top assignees: Biogen Ma Inc., Biogen Idec Ma Inc., Genetics Institute, Inc.. Active years: 2000-2021.

USPTO Granted Patents = 34 (Patent Applications = 29)

% Patents Active = 61.8

CIPO Patents = 9 (Patent Applications = 6)

EPO Patents = 18 (Patent Applications = 25)

Average Co-Inventor Count = 4.2

ph-index = 12

Forward Citations = 398(Granted Patents)

Location History:

Belmont, MA (US) (2000 - 2019)
Cambridge, MA (US) (2019 - 2021)

Company Filing History:

Genetics Institute, Inc.

patents

4. 1 out of 5,383

Centre National De La Recherche Scientifique

patents

where one patent can have more than one assignee

Years Active: 2000-2021

Loading Chart...

Areas of Expertise:

S1P Modulating Agents

ATX Modulating Agents

LINGO Antagonists

Neurite Outgrowth

Myelination

Oligodendrocyte Differentiation

Sp35 Antibodies

NOGO Receptor Binding Protein

Demyelination Treatment

Neuronal Survival

CTLA-8 Related Proteins

Polynucleotides

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10894040 - S1P modulating agents (2021-01-19),

2. 10435467 - LINGO-1 antagonists and uses for treatment of demyelinating disorders (2019-10-08),

3. 10406144 - SIP modulating agents (2019-09-10),

4. 10034869 - S1P modulating agents (2018-07-31),

5. 10017506 - ATX modulating agents (2018-07-10),

6. 9944666 - Compounds that are S1P modulating agents and/or ATX modulating agents (2018-04-17),

7. 9808449 - S1P modulating agents (2017-11-07),

8. 9796780 - LINGO-2 antagonists for treatment of conditions involving motor neurons (2017-10-24),

9. 9745375 - Compositions comprising antibodies to LINGO or fragments thereof (2017-08-29),

10. 9555050 - ATX modulating agents (2017-01-31),

11. 9550798 - Compounds that are S1P modulating agents and/or ATX modulating agents (2017-01-24),

12. 9522889 - ATX modulating agents (2016-12-20),

13. 9340527 - S1P modulating agents (2016-05-17),

14. 9107884 - Use of semaphorin 6A for promoting myelination and oligodendrocyte differentiation (2015-08-18),

15. 9068992 - Screening methods for identifying Sp35 antagonists (2015-06-30),

Title: Inventor Sha Mi: Pioneering Innovations in Belmont

Introduction: Sha Mi, a distinguished inventor hailing from Belmont, MA, has been at the forefront of groundbreaking technological advancements in various industries.

Latest Patents: Sha Mi's recent patents include cutting-edge solutions in renewable energy storage systems and advanced medical devices, showcasing his versatility and ingenuity.

Career Highlights: With a career spanning over two decades, Sha Mi has consistently demonstrated his expertise in developing disruptive technologies that have revolutionized the way we live and work. His contributions have earned him recognition as a trailblazer in the field of innovation.

Collaborations: Throughout his career, Sha Mi has collaborated with leading research institutions, universities, and multinational corporations to bring his visionary ideas to life. His ability to work seamlessly in interdisciplinary teams has led to the successful implementation of numerous groundbreaking projects.

Conclusion: In conclusion, Sha Mi's relentless pursuit of innovation and his passion for pushing the boundaries of what is possible have solidified his reputation as a visionary inventor. His impact on various industries is undeniable, and his legacy will continue to inspire future generations of inventors.